换一批
换一批Susceptibility of low-density lipoprotein particles to aggregate depends on particle lipidome, is modifiable, and associates with future cardiovascular deaths.
作者：
Maija,Ruuth [1]
;
Su Duy,Nguyen [2]
;
Terhi,Vihervaara [1]
;
Mika,Hilvo [3]
;
Teemu D,Laajala [3]
;
Pradeep Kumar,Kondadi [4]
;
Anton,Gisterå [5]
;
Hanna,Lähteenmäki [6]
;
Tiia,Kittilä [7]
;
Jenni,Huusko [1]
;
Matti,Uusitupa [1]
;
Ursula,Schwab [8]
;
Markku J,Savolainen [9]
;
Juha,Sinisalo [9]
;
Marja-Liisa,Lokki [10]
;
Markku S,Nieminen [11]
;
Antti,Jula [12]
;
Markus,Perola [13]
;
Seppo,Ylä-Herttula [14]
;
Lawrence,Rudel [13]
;
Anssi,Öörni [15]
;
Marc,Baumann [15]
;
Amos,Baruch [16]
;
Reijo,Laaksonen [8]
;
Daniel F J,Ketelhuth [17]
;
Tero,Aittokallio [18]
;
Matti,Jauhiainen [19]
;
Reijo,Käkelä [20]
;
Jan,Borén [21]
;
Kevin Jon,Williams [3]
;
Petri T,Kovanen [22]
;
Katariina,Öörni [23]
作者单位：
Atherosclerosis Research Laboratory, Wihuri Research Institute, Haartmaninkatu 8, 00290 Helsinki, Finland.
[1]
Research Programs Unit, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, P.O. Box 63, 00014 University of Helsinki, Finland.
[2]
Zora Biosciences, Biologinkuja 1, 02150 Espoo, Finland.
[3]
Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Tukholmankatu 8, P.O. Box 20, 00014 University of Helsinki, Finland.
[4]
Department of Mathematics and Statistics, University of Turku, Vesilinnantie 5, 20014 University of Turku, Finland.
[5]
Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, SU Sahlgrenska, 41345 Gothenburg, Sweden.
[6]
Department of Medicine, Karolinska University Hospital, Karolinska Institute, Solna 171 76 Stockholm, Sweden.
[7]
Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, 70211 Kuopio, Finland.
[8]
Institute of Public Health and Clinical Nutrition, School of Medicine, University of Eastern Finland, Yliopistonranta 1, P.O. Box 1627, 70211 Kuopio, Finland.
[9]
Institute of Clinical Medicine, Internal Medicine, Kuopio University Hospital, Puijonlaaksontie 2, P.O. Box 100, 70029 Kuopio, Finland.
[10]
Research Unit of Internal Medicine, University of Oulu, Pentti Kaiteran katu 1, P.O. Box 8000, 90014, Oulu, Finland.
[11]
Medical Research Center, Oulu University Hospital, Pentti Kaiteran katu 1, P.O. Box 8000, 90014 Oulu, Finland.
[12]
Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, P.O. Box 340, 00029 Helsinki, Finland.
[13]
Transplantation Laboratory, Medicum, University of Helsinki, Haartmaninkatu 3, P.O. Box 21, 00014 Helsinki, Finland.
[14]
Genomics and Biomarkers Unit, Department of Health, National Institute for Health and Welfare, Genomics and Biomarkers Unit, Mannerheimintie 166, P.O. Box 30, 00271 Helsinki, Finland.
[15]
Institute for Molecular Medicine Finland and Diabetes and Obesity Research Program, University of Helsinki, Haartmaninkatu 8, P.O. Box 63, 00014 University of Helsinki, Finland.
[16]
Heart Center and Gene Therapy Unit, Kuopio University Hospital, Puijonlaaksontie 2, P.O. Box 100, 70029 Kuopio, Finland.
[17]
Department of Biochemistry Wake Forest School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA.
[18]
Information Systems, Åbo Akademi University, Fänriksgatan 3A, 20500 Turku, Finland.
[19]
Meilahti Clinical Proteomics Core Facility, Faculty of Medicine, University of Helsinki, Haartmaninkatu 8, P.O. Box 63, 00014 University of Helsinki, Finland.
[20]
Genentech Research and Early Development, 1 DNA Way Mailstop 258A, South San Francisco, CA 94080, USA.
[21]
Finnish Cardiovascular Research Center, University of Tampere, Kalevantie 4, 33100 Tampere, Finland.
[22]
Finnish Clinical Biobank Tampere, University Hospital of Tampere, Arvo Ylpön katu 6, 33520 Tampere, Finland.
[23]
Minerva Foundation Institute for Medical Research, Tukholmankatu 8, 00290 Helsinki, Finland.
[24]
Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Viikinkaari 1, P.O. Box 65, 00014 University of Helsinki, Finland.
[25]
Helsinki University Lipidomics Unit, Helsinki Institute for Life Science (HiLIFE), Viikinkaari 1, P.O. Box 65, 00014 University of Helsinki, Finland.
[26]
主题词
成年人(Adult);动物(Animals);冠状动脉疾病(Coronary Artery Disease);女(雌)性(Female);人类(Humans);脂类(Lipids);脂蛋白类, LDL(Lipoproteins, LDL);男(雄)性(Male);小鼠(Mice);中年人(Middle Aged);预后(Prognosis);危险性评估(Risk Assessment)
DOI
10.1093/eurheartj/ehy319
PMID
29982602
发布时间
2019-11-27
- 浏览4
European heart journal
European heart journal
2562-2573页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
